Pharmacogenetic Approach to Toxicity in Breast Cancer Patients Treated with Taxanes

被引：11
|
作者：
Angelini, Silvia [1 ,2 ]
Botticelli, Andrea [1 ]
Onesti, Concetta Elisa [1 ,2 ]
Giusti, Raffaele [2 ]
Sini, Valentina [1 ,3 ]
Durante, Valeria [1 ,2 ]
Strigari, Lidia [4 ]
Gentile, Giovanna [5 ]
Cerbelli, Bruna [6 ]
Pellegrini, Patrizia [2 ]
Sgroi, Valentina [1 ,2 ]
Occhipinti, Mario [1 ,2 ]
Di Pietro, Francesca Romana [1 ,2 ]
Rossi, Alessandro [7 ]
Simmaco, Maurizio [8 ]
Mazzuca, Federica [1 ,2 ]
Marchetti, Paolo [1 ,2 ,5 ]
机构：
[1] Sapienza Univ Rome, Dept Clin & Mol Med, Rome, Italy
[2] St Andrea Hosp, Dept Med Oncol, Via Grottarossa 1035, I-00189 Rome, Italy
[3] Santo Spirito Hosp, Rome, Italy
[4] Regina Elena Inst Canc Res, Lab Med Phys & Expert Syst, Rome, Italy
[5] Immacolata IDI IRCSS, Dermopat Inst, Rome, Italy
[6] Sapienza Univ Rome, Dept Radiol Oncol & Pathol Sci, Rome, Italy
[7] Sapienza Univ Rome, Fac Med & Psychol, Rome, Italy
[8] Sapienza Univ Rome, Dept Neurosci Mental Hlth & Sensory Organs NESMOS, Rome, Italy
来源：
ANTICANCER RESEARCH | 2017年 / 37卷 / 05期
关键词：
Breast cancer; taxanes; polymorphisms; ABCB1; P-gp; cytochrome P450; GENETIC POLYMORPHISMS; PERIPHERAL NEUROPATHY; RANDOMIZED-TRIAL; OVARIAN-CANCER; HUMAN LIVER; PACLITAXEL; ABCB1; DOCETAXEL; EXPRESSION; CHEMOTHERAPY;
D O I：
10.21873/anticanres.11610
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background: Taxanes are widely used to treat breast cancer patients. Taxanes are metabolized in human liver by the cytochrome CYP3A and are substrate of ATP-binding cassette multidrug transporters ABCB1. Single-nucleotide polymorphisms (SNPs) in genes involved in taxanes' metabolism could affect the inter-individual variability in reported toxicities. Materials and Methods: In this retrospective study, 152 women, affected by breast cancer and receiving a taxane-based chemotherapy, were enrolled. A peripheral blood sample was taken for genotyping the following polymorphisms: CYP3A4* 1B (A>G), CYP3A5 * 3 (G>A) and ABCB1 (C1236T; C3435T). Results: We observed an association between ABCB1 3435 T/T and lower grade of toxicities (p=0.05). No other association were found for CYP 3A4 * 1B, 3A5*3 and ABCB1 C1236T. Conclusion: ABCB1 3435 T/T seems to be associated to lower rate of toxicity in patients receiving taxanes. Further prospective and larger studies should be performed to clarify the role of this polymorphism.
引用
收藏
页码：2633 / 2639
页数：7
相关论文
共 50 条
  • [21] LONGITUDINAL CHANGES IN MULTIPLE BIOMARKERS ARE ASSOCIATED WITH CARDIOTOXICITY IN BREAST CANCER PATIENTS TREATED WITH DOXORUBICIN, TAXANES AND TRASTUZUMAB
    Hahn, Virginia Shalkey
    Putt, Mary
    Sawaya, Heloisa
    Januzzi, James
    Sebag, Igal A.
    Plana, Juan
    Picard, Michael
    Gerszten, Robed
    Halpern, Elkan
    Kuter, Irene
    Martin, Randolph
    Carver, Joseph
    Scherrer-Crosbie, Marielle
    Ky, Bonnie
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A1001 - A1001
  • [22] Early Increases in Biomarkers Predict Subsequent Cardiotoxicity in Breast Cancer Patients Treated With Doxorubicin, Taxanes, and Trastuzumab
    Putt, Mary
    Ky, Bonnie
    Sawaya, Heloisa
    French, Benjamin
    Januzzi, James L.
    Sebag, Igal
    Planas, Juan
    Cohen, Victor
    Blanchs, Jose
    Carver, Joseph
    Wiegers, Susan
    Martin, Randolph P.
    Picard, Michael
    Gerstzen, Robert
    Halpern, Elkan
    Passeri, Jonathan
    Irene, Kuter
    Scherrer-Crosbie, Marielle
    CIRCULATION, 2013, 128 (22)
  • [23] Predictors of chemotherapy-induced peripheral neuropathy among breast cancer patients treated with taxanes.
    Candelario, Nellowe
    Wongrakpanich, Supakanya
    Morginstin, Mark S.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (28)
  • [24] Outcomes and Early Toxicity in Patients Treated With Proton Therapy for Breast Cancer
    Cuaron, J. J.
    Hug, E.
    Chon, B. H.
    Tsai, H.
    Powell, S. N.
    Cahlon, O.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S220 - S220
  • [25] Taxanes as adjuvant for breast cancer
    Goldhirsch, A
    Francis, P
    Castiglione-Gertsch, M
    Gelber, RD
    Coates, AS
    LANCET, 2000, 356 (9228): : 507 - 508
  • [26] Taxanes in breast cancer: An update
    Conlin A.K.
    Seidman A.D.
    Current Oncology Reports, 2007, 9 (1) : 22 - 30
  • [27] Helical tomotherapy and breast cancer: skin toxicity of the first 85 breast cancer patients treated with tomotherapy
    Uhl, M.
    Sterzing, E.
    Habl, G.
    Schubert, K.
    Debus, J.
    Herfarth, K.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 (10) : 689 - 689
  • [28] Pharmacogenetic personalised treatment of breast cancer in young patients
    Ibragimov, J.
    Pulatov, D.
    Kamishov, S.
    BREAST, 2016, 29 : S22 - S23
  • [29] Anthracycline cardiotoxicity in breast cancer patients: synergism with trastuzumab and taxanes
    Gianni, Luca
    Salvatorelli, Emanuela
    Minotti, Giorgio
    CARDIOVASCULAR TOXICOLOGY, 2007, 7 (02) : 67 - 71
  • [30] An array-based pharmacogenetic study on elderly patients with advanced breast cancer treated with aromatase inhibitors
    Rumiato, E.
    Brunello, A.
    Ahcene-Djaballah, S.
    Borgato, L.
    Gusella, M.
    Pasini, F.
    Fiduccia, P.
    Amadori, A.
    Zagonel, V.
    Saggioro, D.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S155 - S155
12345